News & Events | Applied StemCell

December 04, 2023 9:00 AM Eastern Standard Time MILPITAS, Calif.--Applied StemCell, Inc., a leading CRO/CDMO recognized for its proprietary TARGATT gene editing technology and expertise in stem cells and cell therapy development, is pleased to announce the addition of   ...Read more

Strategic Financial Sponsor to Support Continued Growth and Market Expansion RALEIGH, NC and MILPITAS, CA, October 9, 2023 – QHP Capital (“QHP”), today announced its acquisition of Applied Stem Cell, Inc. (“ASC” or the “Company”), a leading cell and   ...Read more

Applied StemCell Inc. partners with CIRM to provide clinical-grade iPSCs and access to its proprietary gene editing technologies to accelerate the development of regenerative therapies Milpitas, CA USA, 13 June 2023: Applied StemCell, Inc. (ASC) and the California Institute for   ...Read more

Milpitas, California, August 29, 2022 -- Applied StemCell, Inc. (ASC), a leading cell and gene therapy CRO/CDMO focused on supporting the research community and biotechnology industry for their needs in developing and manufacturing cell and gene products, today announced   ...Read more

Milpitas, California, August 3, 2021 -- Applied StemCell, Inc.’s GMP facility is Now Fully Licensed and Ready for Drug Product Manufacturing. Applied StemCell (ASC), a fast-growing Gene & Cell Therapy CRO, today announced that the California Department of Public   ...Read more